Food and Drug Administration Drug Safety Podcast
About This Show
FDA Drug Safety Podcasts.
Most Recent Episode
FDA Drug Safety Podcast: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq)
2 days ago
On May 18, 2018, FDA alerted the public that serious cases of neural tube birth defects involving the brain, spine, and spinal cord have been reported in babies born to women treated with dolutegravir used to treat human immunodeficiency virus (or HIV).
Episodes of This Show
Nov 20, 2017